S100A9 Alters the Pathway of Alpha-Synuclein Amyloid Aggregation.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Jul 2021
Historique:
received: 29 06 2021
revised: 18 07 2021
accepted: 19 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 9 9 2021
Statut: epublish

Résumé

The formation of amyloid fibril plaques in the brain creates inflammation and neuron death. This process is observed in neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases. Alpha-synuclein is the main protein found in neuronal inclusions of patients who have suffered from Parkinson's disease. S100A9 is a calcium-binding, pro-inflammation protein, which is also found in such amyloid plaques. To understand the influence of S100A9 on the aggregation of α-synuclein, we analyzed their co-aggregation kinetics and the resulting amyloid fibril structure by Fourier-transform infrared spectroscopy and atomic force microscopy. We found that the presence of S100A9 alters the aggregation kinetics of α-synuclein and stabilizes the formation of a particular amyloid fibril structure. We also show that the solution's ionic strength influences the interplay between S100A9 and α-synuclein, stabilizing a different structure of α-synuclein fibrils.

Identifiants

pubmed: 34360737
pii: ijms22157972
doi: 10.3390/ijms22157972
pmc: PMC8348003
pii:
doi:

Substances chimiques

Amyloid 0
Calgranulin B 0
Protein Aggregates 0
Recombinant Proteins 0
S100A9 protein, human 0
SNCA protein, human 0
alpha-Synuclein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Lietuvos Mokslo Taryba
ID : S-SEN-20-3
Organisme : Lithuania and State Education Development Agency of Latvia
ID : PostDoc Latvia project no. 1.1.1.2/VIAA/2/18/374

Références

Sci Rep. 2017 Jan 23;7:41051
pubmed: 28112214
J Phys Chem B. 2019 May 23;123(20):4380-4386
pubmed: 31034772
Prion. 2012 Apr-Jun;6(2):184-90
pubmed: 22460692
Int J Mol Sci. 2012;13(3):2893-917
pubmed: 22489132
Acta Neuropathol. 1998 Nov;96(5):445-52
pubmed: 9829807
Ann Pharmacother. 2020 May;54(5):470-477
pubmed: 31735059
Am J Pathol. 1998 Apr;152(4):879-84
pubmed: 9546347
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1430-5
pubmed: 15671169
Methods Mol Biol. 2013;931:295-312
pubmed: 23027008
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):3-7
pubmed: 23227278
J Neuroinflammation. 2018 Jun 4;15(1):172
pubmed: 29866153
Neurology. 2013 May 7;80(19):1778-83
pubmed: 23390181
PLoS One. 2014 Mar 05;9(3):e90659
pubmed: 24599158
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050
pubmed: 32695874
Annu Rev Biochem. 2017 Jun 20;86:27-68
pubmed: 28498720
PeerJ. 2015 Sep 24;3:e1271
pubmed: 26421240
Methods. 2011 Mar;53(3):295-305
pubmed: 21163351
Amyloid. 2017 Mar;24(1):1-16
pubmed: 28393556
Biochim Biophys Acta. 2013 Jan;1835(1):100-9
pubmed: 23123827
ACS Chem Neurosci. 2017 Oct 18;8(10):2152-2158
pubmed: 28759719
J Biol Chem. 2020 May 22;295(21):7470-7480
pubmed: 32291284
J Biol Chem. 1998 May 15;273(20):12427-35
pubmed: 9575199
Sci Rep. 2018 Aug 27;8(1):12836
pubmed: 30150640
Chem Sci. 2020 Jun 17;11(27):7031-7039
pubmed: 34122996
Expert Opin Investig Drugs. 2017 Jun;26(6):735-739
pubmed: 28460541
Neurosci Lett. 2019 Apr 23;699:199-205
pubmed: 30753908
Int J Mol Sci. 2020 Nov 24;21(23):
pubmed: 33255444
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Neurosci Lett. 1998 Jun 19;249(2-3):180-2
pubmed: 9682846
Biochim Biophys Acta Proteins Proteom. 2019 Jul - Aug;1867(7-8):701-709
pubmed: 31096048
Biochemistry. 2004 Dec 28;43(51):16233-42
pubmed: 15610017
Biophys Chem. 2009 Mar;140(1-3):9-15
pubmed: 19101068
Nat Commun. 2013;4:2575
pubmed: 24108358
Sci Rep. 2020 Mar 12;10(1):4572
pubmed: 32165692
Curr Biol. 2014 Oct 6;24(19):2319-26
pubmed: 25264250
FEBS Lett. 1998 Oct 9;436(3):309-12
pubmed: 9801138
Nat Neurosci. 2017 Nov;20(11):1569-1579
pubmed: 28945221
Biochim Biophys Acta. 2007 Sep;1767(9):1073-101
pubmed: 17692815
Molecules. 2020 Jan 29;25(3):
pubmed: 32013170
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
Nat Commun. 2019 Dec 4;10(1):5535
pubmed: 31797870
Acta Neuropathol. 2014 Apr;127(4):507-22
pubmed: 24240735
J Leukoc Biol. 1993 Feb;53(2):197-204
pubmed: 8445331
Int J Biol Macromol. 2016 Feb;83:433-41
pubmed: 26601760
ACS Chem Neurosci. 2016 Jan 20;7(1):34-9
pubmed: 26550994
Acta Neuropathol. 2020 Jun;139(6):977-1000
pubmed: 32356200
Commun Biol. 2020 Jul 9;3(1):365
pubmed: 32647130
Biomolecules. 2019 Dec 11;9(12):
pubmed: 31835741

Auteurs

Zigmantas Toleikis (Z)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.
Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.

Mantas Ziaunys (M)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Lina Baranauskiene (L)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Vytautas Petrauskas (V)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Kristaps Jaudzems (K)

Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.

Vytautas Smirnovas (V)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH